Laser devices for vaginal rejuvenation: effectiveness, regulation and marketing

Blayne Welk, Erin Kelly
In: Canadian Medical Association Journal · 2023 · vol. 195(5) , pp. E195–E196 · doi:10.1503/cmaj.221208 · PMID:36746476 · W4319321304
article OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher

Abstract

KEY POINTS In the mid-2010s, vaginal energy devices (such as fractional CO2 lasers, erbium-doped yttrium aluminium garnet lasers [Er:YAG], diode lasers or radiofrequency ablation) emerged as a new potential treatment for genitourinary sydrome of menopause (GSM). A clinical diagnosis of GSM requires

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (13)

SciLite annotations

chemicals 4
erbium yttrium aluminium collagen

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:26:01.642840+00:00
License: CC0 · commercial use OK